301 related articles for article (PubMed ID: 19659473)
41. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
[TBL] [Abstract][Full Text] [Related]
42. Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts.
Sánchez-Moya AI; Daudén E
Br J Dermatol; 2011 Jan; 164(1):208-9. PubMed ID: 21054332
[No Abstract] [Full Text] [Related]
43. Does an interferon-gamma release assay change practice in possible latent tuberculosis?
Tiernan JF; Gilhooley S; Jones ME; Chalmers JD; McSparron C; Laurenson IF; Hill AT
QJM; 2013 Feb; 106(2):139-46. PubMed ID: 23159840
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
[TBL] [Abstract][Full Text] [Related]
45. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
Amorim RF; Viegas ERC; Carneiro AJV; Esberard BC; Chinem ES; Correa RS; Rodrigues L; Ribeiro-Alves M; Silva KS; de Souza HS; Carvalho ATP
Dig Dis Sci; 2019 Jul; 64(7):1916-1922. PubMed ID: 30673986
[TBL] [Abstract][Full Text] [Related]
46. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
Davidow AL
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
[TBL] [Abstract][Full Text] [Related]
48. Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.
Sánchez-Moya AI; Dauden E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):730-3. PubMed ID: 21564322
[TBL] [Abstract][Full Text] [Related]
49. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
[TBL] [Abstract][Full Text] [Related]
50. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
[TBL] [Abstract][Full Text] [Related]
51. Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis.
Tsiouri G; Gaitanis G; Kiorpelidou D; Dionysiou A; Efthymiou A; Daskalopoulos G; Constantopoulos S; Bassukas ID
Dermatology; 2009; 219(2):119-25. PubMed ID: 19478478
[TBL] [Abstract][Full Text] [Related]
52. Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers.
Bellofiore B; Matarese A; Balato N; Gaudiello F; Scarpa R; Atteno M; Bocchino M; Sanduzzi A
J Rheumatol Suppl; 2009 Aug; 83():76-7. PubMed ID: 19661550
[TBL] [Abstract][Full Text] [Related]
53. Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
Martin J; Walsh C; Gibbs A; McDonnell T; Fearon U; Keane J; Codd MB; Dodd J; Veale D; Fitzgerald O; Bresnihan B
Ann Rheum Dis; 2010 Jan; 69(1):181-5. PubMed ID: 19176545
[TBL] [Abstract][Full Text] [Related]
54. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.
Goletti D; Sanduzzi A; Delogu G
J Rheumatol Suppl; 2014 May; 91():24-31. PubMed ID: 24788997
[TBL] [Abstract][Full Text] [Related]
55. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
[TBL] [Abstract][Full Text] [Related]
56. Clinical applicability of T-cell interferon-a release assay for tumour necrosis factor-a inhibitor therapy in severe psoriasis.
Chiang YZ; Panting K; Dever B; Parslew RA
Clin Exp Dermatol; 2011 Jan; 36(1):39-41. PubMed ID: 20456401
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation.
Kim SH; Lee SO; Park IA; Park SJ; Choi SH; Kim YS; Woo JH; Park SK; Park JS; Kim SC; Han DJ
Transpl Infect Dis; 2010 Apr; 12(2):113-9. PubMed ID: 20113458
[TBL] [Abstract][Full Text] [Related]
58. Interferon-gamma-release assays: Better than tuberculin skin testing?
Miranda C; Tomford JW; Gordon SM
Cleve Clin J Med; 2010 Sep; 77(9):606-11. PubMed ID: 20810871
[TBL] [Abstract][Full Text] [Related]
59. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of tuberculosis in dialysis patients: current strategy.
Segall L; Covic A
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1114-22. PubMed ID: 20413440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
